Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol

November 2004

Researchers are excited about Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol.

The lay press has picked up on this too-good-to-be-true drug, and people are asking about it.

It's the first in a new class...called selective cannabinoid type 1 (CB1) blockers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote